HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yanyan Long Selected Research

SH2 Domain-Containing Protein Tyrosine Phosphatases

5/2022Pharmaceutical SH2 domain-containing protein tyrosine phosphatase 2 inhibition suppresses primary and metastasized liver tumors by provoking hepatic innate immunity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yanyan Long Research Topics

Disease

3Neoplasms (Cancer)
05/2022 - 05/2014
1Liver Neoplasms (Liver Cancer)
05/2022
1Hypoxia (Hypoxemia)
03/2022
1Lung Neoplasms (Lung Cancer)
03/2022
1Breast Neoplasms (Breast Cancer)
01/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
05/2014
1Neoplasm Metastasis (Metastasis)
05/2014

Drug/Important Bio-Agent (IBA)

1SH2 Domain-Containing Protein Tyrosine PhosphatasesIBA
05/2022
1Pharmaceutical PreparationsIBA
05/2022
1PolyphenolsIBA
03/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2022
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
03/2022
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2022
1Caspase 9IBA
03/2022
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
03/2022
1TOR Serine-Threonine KinasesIBA
03/2022
1Messenger RNA (mRNA)IBA
03/2022
1Biomarkers (Surrogate Marker)IBA
01/2022

Therapy/Procedure

1Immunotherapy
05/2014
1Therapeutics
05/2014
1Drug Therapy (Chemotherapy)
05/2014